Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment initiation: a biomarker for assessment of anti-tuberculosis treatment-ANRS 12394
Rapid decrease in IL-1Ra and IP-10 plasma levels following tuberculosis treatment Initiation: a biomarker for assessment of anti-tuberculosis treatment- ANRS 12394 Tuberculosis (TB) remains a major public health issue with 10.6 million incident cases and 1.6 million deaths in 2022. The lack of microbiologically confirmed TB is frequent, especially in resource-limited settings and people with … Read more